YouTube® in Spanish as an information source for patients with autoimmune hepatitis C.E. Lombo-Moreno; O.M. Muñoz-Velandia; D.G. Fernández-Ávila; J.E. Barahona-Correa; H.C. Aranguren; F.A. Avila;

Prevalence of extraintestinal manifestations and other associated conditions in a cohort of patients with inflammatory bowel disease at an advanced specialty center in Bogotá, Colombia J. Andrade-Restrepo; D. Rubio-Cruz; J.G. Maigual-Quintas; S.G. Sicard-Gómez; E.J. Cuello-Navarro; L.C. Álvarez-Larrota; R. García-Duperly; E.E. Londoño-Schimmer; A.M. Rey-Rubiano; B. Mendoza de Molano; R.P. López-Panqueva;

ITPA polymorphisms do not predict additional risk beyond TPMT and NUDT15 for thiopurine-induced cytopenia in inflammatory bowel disease A. Jena; N. Grover; P. Bhatia; M. Singh; D. Lad; K.K. Prasad; H. Singh; U. Dutta; V. Sharma;